Combined epigenetic therapy and immune checkpoint blockade drive reshaping of the tumor microenvironment of platinum resistant ovarian cancer

被引：0
|
作者：
Landon, Blair V.
Kaleka, Guneet
Balan, Archana
Boland, Julia L.
Cherry, Christopher
Pereira, Gavin
Zahnow, Cynthia
Winterhoff, Boris
Baylin, Stephen
Velculescu, Victor E.
Konecny, Gottfried E.
Glaspy, John A.
Anagnostou, Valsamo
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-7551
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7551
引用
收藏
页数：2
相关论文
共 50 条
  • [21] C5aR1 blockade reshapes immunosuppressive tumor microenvironment and synergizes with immune checkpoint blockade therapy in high-grade serous ovarian cancer
    Zhang, Chen
    Cao, Kankan
    Yang, Moran
    Wang, Yiying
    He, Mengdi
    Lu, Jiaqi
    Huang, Yan
    Zhang, Guodong
    Liu, Haiou
    [J]. ONCOIMMUNOLOGY, 2023, 12 (01):
  • [22] Immune Checkpoint Blockade in Cancer Therapy
    Postow, Michael A.
    Callahan, Margaret K.
    Wolchok, Jedd D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (17) : 1974 - U161
  • [23] Carfilzomib modulates tumor microenvironment to potentiate immune checkpoint therapy for cancer
    Zhou, Qian
    Liang, Jinxia
    Yang, Tong
    Liu, Jin
    Li, Bo
    Li, Yingchang
    Fan, Zhenzhen
    Wang, Weida
    Chen, Wensheng
    Yuan, Sujing
    Xu, Meng
    Xu, Qigui
    Luan, Zhidong
    Xia, Zhongjun
    Zhou, Penghui
    Huang, Yadong
    Chen, Liang
    [J]. EMBO MOLECULAR MEDICINE, 2022, 14 (01)
  • [24] Conserved angio-immune subtypes of the tumor microenvironment predict response to immune checkpoint blockade therapy
    Subramanian, Madhav
    Ul Kabir, Ashraf
    Barisas, Derek
    Krchma, Karen
    Choi, Kyunghee
    [J]. CELL REPORTS MEDICINE, 2023, 4 (01)
  • [25] Association of the tumor-immune microenvironment with response to niraparib and pembrolizumab in relapsed, platinum-resistant ovarian cancer
    Farkkila, Anniina
    Lin, Jia R.
    Casado, Julia
    Huy Nguyen
    Zhou, Yinghui
    Graham, Julie R.
    Dezube, Bruce J.
    Waggoner, Steven
    Munster, Pamela
    Fleming, Gini F.
    Santagata, Sandro
    Matulonis, Ursula A.
    Sorger, Peter K.
    Swisher, Elizabeth M.
    D'Andrea, Alan D.
    Konstantinopoulos, Panagiotis
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [26] Exploring the clinical value of tumor microenvironment in platinum-resistant ovarian cancer
    Ghoneum, Alia
    Almousa, Sameh
    Warren, Bailey
    Abdulfattah, Ammar Yasser
    Shu, Junjun
    Abouelfadl, Hebatullah
    Gonzalez, Daniela
    Livingston, Christopher
    Said, Neveen
    [J]. SEMINARS IN CANCER BIOLOGY, 2021, 77 : 83 - 98
  • [27] A novel immune checkpoint regulator in the ovarian cancer microenvironment
    Borgogno, Sammy Ferri
    Yeung, Tsz-Lun
    Leung, Cecilia S.
    Yeung, Chi Lam Au
    Zhu, Ying
    Wong, Stephen T.
    Mok, Samuel C.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [28] A novel immune checkpoint regulator in the ovarian cancer microenvironment
    Borgogno, Sammy Ferri
    Yeung, Tsz-Lun
    Leung, Cecilia S.
    Yeung, Chi Lam Au
    Zhu, Ying
    Wong, Stephen T.
    Mok, Samuel C.
    [J]. CANCER RESEARCH, 2020, 80 (16)
  • [29] The nexus of dynamic T cell states and immune checkpoint blockade therapy in the periphery and tumor microenvironment
    Luo, Hong
    Wang, Wenxiang
    Mai, Jia
    Yin, Rutie
    Cai, Xuyu
    Li, Qintong
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [30] Epigenetic modulation of the tumor microenvironment enhances immune checkpoint efficacy in a murine model of pancreatic cancer
    Christmas, Brian
    Scott, Blake
    Armstrong, Todd
    Azad, Nilofer
    Jaffee, Elizabeth
    [J]. CANCER RESEARCH, 2018, 78 (13)
12345